Search results for "risk factor"

showing 10 items of 4321 documents

Risk of Recurrence After a First Episode of Symptomatic Venous Thromboembolism Provoked by a Transient Risk Factor A Systematic Review

2010

Background We aimed to determine the risk of recurrence for symptomatic venous thromboembolism (VTE) provoked by different transient risk factors. Data Sources MEDLINE, EMBASE, and Cochrane Collaboration Registry of Randomized Trials databases were searched. Study Selection Prospective cohort studies and randomized trials of patients with a first episode of symptomatic VTE provoked by a transient risk factor and treated for at least 3 months were identified. Data Extraction Number of patients and recurrent VTE during the 0- to 12-month and 0- to 24-month intervals after stopping therapy, study design, and provoking risk factor characteristics were extracted. Data Synthesis Annualized recurr…

medicine.medical_specialtyRate ratioRisk Assessmentlaw.inventionRandomized controlled triallawRecurrenceRisk FactorsInternal medicineEpidemiologyInternal MedicinemedicineHumansRisk factorProspective cohort studyFirst episodebusiness.industryIncidence (epidemiology)IncidenceVenous Thromboembolismvenous thrombosis recurrent eventmedicine.diseasePrognosisSurgeryVenous thrombosisbusiness
researchProduct

Complications and Solutions in Propeller Flap Surgery

2020

AbstractPropeller perforator flaps (PPFs) have long been proven as valid reconstructive tools for a wide range of soft tissue defects in different body regions. During the last decade, despite their numerous advantages, many authors have thoroughly analyzed outcomes of these flaps, sometimes discouraging their use mainly because of a high failure rate. Accurate patient selection, adequate preoperative planning, and an appropriate dissection technique seem to potentially improve outcomes. Our study provides a review of the relevant literature related to PPF complications and of our experience, describing reasons for failure, measures for preventing them, and approaches for a prompt evaluatio…

medicine.medical_specialtyReconstructive surgeryPreoperative planningDissection techniquecomplicationsbusiness.industrySettore MED/19 - Chirurgia PlasticaPropellerreconstructive surgeryReview articlerisk factormedicinerisk factorsperforator flapSurgeryBody regionIntensive care medicinebusinessPerforator flapspropeller flapSeminars in Plastic Surgery
researchProduct

Halitosis: could it be more than mere bad breath?

2010

Halitosis is a generic term used to describe unpleasant odor emanating from the mouth air and breath, independent of the source where the odor substances originate. It affects between 50 and 65% of the population, but despite its frequency, this problem is often unaccepted and declared as taboo. Ninety percent of patients suffering from halitosis have oral causes: a small, but important percentage, of oral malodor cases have an extra-oral etiology, very often falling into the category of "blood-borne halitosis". Several systemic diseases have been found to provoke malodor or to be a cofactor; bad breath may be an early sign of a serious local or systemic condition. A psychogenic halitosis a…

medicine.medical_specialtyReferralPopulationDentistryOral HealthPrimary careOral hygieneBad breathRisk FactorsSettore MED/28 - Malattie OdontostomatologicheInternal MedicinemedicineHumansPsychogenic diseaseeducationIntensive care medicineHalitosis Bad breathExtra-oral halitosis Intra-oral halitosiseducation.field_of_studySettore MED/12 - Gastroenterologiabusiness.industryHalitosisOral HygieneOdorEmergency MedicineEtiologymedicine.symptomMouth Diseasesbusiness
researchProduct

EU-wide cross-sectional observational study of lipid-modifying therapy use in secondary and primary care: the DA VINCI study

2021

Abstract Aims To provide contemporary data on the implementation of European guideline recommendations for lipid-lowering therapies (LLTs) across different settings and populations and how this impacts low-density lipoprotein cholesterol (LDL-C) goal achievement. Methods and results An 18 country, cross-sectional, observational study of patients prescribed LLT for primary or secondary prevention in primary or secondary care across Europe. Between June 2017 and November 2018, data were collected at a single visit, including LLT in the preceding 12 months and most recent LDL-C. Primary outcome was the achievement of risk-based 2016 European Society of Cardiology (ESC)/European Atherosclerosis…

medicine.medical_specialtyRegistryStatinEpidemiologymedicine.drug_class030204 cardiovascular system & hematologyGuidelinesSecondary care03 medical and health sciences0302 clinical medicineEzetimibeRisk FactorsInternal medicinemedicineHumans030212 general & internal medicinePCSK9 InhibitorsDyslipidemiasSecondary preventionPrimary Health Carebusiness.industryAnticholesteremic AgentsStatinsCholesterol LDLGuidelineLipidsConfidence intervalCross-Sectional StudiesTreatment OutcomeCholesterolCardiovascular DiseasesObservational studyHydroxymethylglutaryl-CoA Reductase InhibitorsProprotein Convertase 9Cardiology and Cardiovascular MedicinebusinessBiomarkersmedicine.drugDA VINCI study
researchProduct

Fructose and cardiometabolic disorders: the controversy will, and must, continue

2010

The present review updates the current knowledge on the question of whether high fructose consumption is harmful or not and details new findings which further pushes this old debate. Due to large differences in its metabolic handling when compared to glucose, fructose was indeed suggested to be beneficial for the diet of diabetic patients. However its growing industrial use as a sweetener, especially in soft drinks, has focused attention on its potential harmfulness, possibly leading to dyslipidemia, obesity, insulin resistance/metabolic syndrome and even diabetes. Many new data have been generated over the last years, confirming the lipogenic effect of fructose as well as risks of vascular…

medicine.medical_specialtyReviewFructoseBiologyBioinformaticschemistry.chemical_compoundInsulin resistanceRisk FactorsInternal medicineDiabetes mellitusmedicineHumansVascular DiseasesTriglyceridesHypertriglyceridemialcsh:R5-920HypertriglyceridemiaFructoseGeneral Medicinemedicine.diseaseObesityMetabolic syndromeDietEndocrinologychemistryLiverSweetening AgentsHypertensionUric acidMetabolic syndromelcsh:Medicine (General)Uric acidDyslipidemiaClinics
researchProduct

Prevalence of human papillomavirus in the saliva of sexually active women with cervical intraepithelial neoplasias

2020

Background The main objective of this study was to estimate the prevalence of human papillomavirus-DNA (HPV-DNA) in the saliva of sexually active women with HPV-related cervical intraepithelial neoplasias (CIN) and compare the findings with a healthy control group. The secondary objectives were: 1) to determine the concordance between genital and oral HPV types in sexually active women with HPV-related CIN; 2) to analyze whether sexual habits influence the presence of HPV-related CIN; 3) to determine whether sexual habits influence the presence of oral HPV. Material and Methods Saliva samples were collected from 100 sexually active women, 50 with HPV-related CIN and 50 healthy subjects pres…

medicine.medical_specialtySalivaConcordanceUterine Cervical NeoplasmsCervical intraepithelial neoplasialaw.invention03 medical and health sciencesSexually active0302 clinical medicineCondomRisk FactorslawPrevalencemedicineHumansSex organPapillomaviridaeSalivaPapillomaviridaeGeneral DentistryOral Medicine and PathologybiologyObstetricsbusiness.industryResearchPapillomavirus Infectionsvirus diseases030206 dentistry:CIENCIAS MÉDICAS [UNESCO]Uterine Cervical Dysplasiabiology.organism_classificationmedicine.diseasefemale genital diseases and pregnancy complicationsOtorhinolaryngologyUNESCO::CIENCIAS MÉDICASMarital statusFemaleSurgerybusinessMedicina Oral Patología Oral y Cirugia Bucal
researchProduct

Normierung und Evaluation der Messinvarianz der 8-Item-Kurzform der Center of Epidemiological Studies-Depression Scale (CES-D-8)

2020

Measurement invariance and normative data of the 8-item short form of the Center of Epidemiological Studies-Depression Scale (CES-D-8) Objectives: Female gender is a risk factor for depression. It is questionable whether a given psychometric instrument depicts depressive symptom severity in men and women alike. Therefore, we examined measurement invariance of the Center of Epidemiological Studies Depression Scale-8 (CES-D-8) between women, men and different age groups. Additionally, we aimed providing normative data for CES-D-8. Methods: We assessed depressive symptoms in a German population-based sample (N = 2,507) with the CES-D-8. Gender-distorted items were excluded in the short form. R…

medicine.medical_specialtySample (statistics)behavioral disciplines and activitieshumanitiesConfirmatory factor analysisScale (social sciences)EpidemiologymedicineNormativeMeasurement invarianceRisk factorPsychologyDepression (differential diagnoses)Clinical psychologyZeitschrift für Psychosomatische Medizin und Psychotherapie
researchProduct

Correlating heatwaves and relative humidity with suicide (fatal intentional self-harm)

2021

AbstractEmpirical evidence suggests that the effects of anthropogenic climate change, and heat in particular, could have a significant impact on mental health. This article investigates the correlation between heatwaves and/or relative humidity and suicide (fatal intentional self-harm) on a global scale. The covariance between heat/humidity and suicide was modelled using a negative binomial Poisson regression with data from 60 countries between 1979–2016. Statistically significant increases and decreases in suicide were found, as well as many cases with no significant correlation. We found that relative humidity showed a more significant correlation with suicide compared to heatwaves and th…

medicine.medical_specialtySciencePopulationNegative binomial distributionArticlesymbols.namesakeEpidemiologymedicineRelative humidityVDP::Medisinske Fag: 700Poisson regressioneducationeducation.field_of_studyMultidisciplinarybusiness.industryQGlobal warmingRNatural hazardsHumidityfood and beveragesMental healthhumanitiesRisk factorssymbolsMedicinebusinessDemography
researchProduct

Is MRI imaging in pediatric age totally safe? A critical reprisal.

2017

Current radiological literature is strongly focussed on radiation imaging risks. Indeed, given there is a small but actual augment in cancer risk from exposure to ionizing radiation in children, it is important to understand what the risk of alternative techniques could be. We retrospectively review literature data concerning possible MR imaging risks, focussing on the biological effects of MR, sedation and gadolinium compound risks when dealing with infant patients. The main concerns can be summarized in: (1) Biological effects of non-ionizing electromagnetic fields (EMF) employed—whose mechanisms of interaction with human tissues are polarization, induced current, and thermal heating, res…

medicine.medical_specialtySedationContrast MediaRisk Assessment030218 nuclear medicine & medical imaging03 medical and health sciencesPatient safety0302 clinical medicineElectromagnetic FieldsRisk FactorsMedicineHumansRadiology Nuclear Medicine and imagingGeneral anaesthesiaNeuroradiologyPaediatric populationmedicine.diagnostic_testbusiness.industryRisk FactorInfant NewbornInfantMagnetic resonance imagingInterventional radiologyGeneral MedicineMRForeign BodiesForeign BodieMagnetic Resonance ImagingElectromagnetic FieldRadiological weaponRadiologyPatient SafetySafetymedicine.symptombusinessRisk assessmentNoise030217 neurology & neurosurgeryHumanLa Radiologia medica
researchProduct

Current insights into the German lipoprotein apheresis standard: PCSK9-inhibitors, lipoprotein apheresis or both?

2017

Abstract According to current European guidelines, lipid lowering therapy for progressive cardiovascular disease including cardiovascular events has to be focused on a target level for LDL-C. In contrast for Lp(a) a threshold has to be defined with respect to the method of measurement. However, due to new lipid lowering drug developments like PCSK9-inhibitors (PCSK-9-I) a therapeutic algorithm for patients with severe hypercholesterolemia or isolated Lipoprotein(a)-hyperlipoproteinemia with progressive cardiovascular disease may be necessary to manage the use of PCSK9-I, lipoprotein apheresis (LA) or both. The therapeutic approach for patients with homozygous familial hypercholesterolemia i…

medicine.medical_specialtySerine Proteinase InhibitorsDiseaseFamilial hypercholesterolemia030204 cardiovascular system & hematologyRisk AssessmentHyperlipoproteinemia Type II03 medical and health sciencesTherapeutic approach0302 clinical medicineRisk FactorsInternal medicineGermanyInternal MedicinemedicineHumans030212 general & internal medicinePCSK9 Inhibitorsbiologybusiness.industryPCSK9Anticholesteremic AgentsPCSK9 InhibitorsGeneral MedicineLipoprotein(a)Cholesterol LDLmedicine.diseaseCombined Modality TherapyEndocrinologyTreatment OutcomeCardiovascular Diseasesbiology.proteinCardiologyBlood Component Removallipids (amino acids peptides and proteins)Proprotein Convertase 9Cardiology and Cardiovascular MedicinebusinessLipoprotein apheresisBiomarkersLipoproteinLipoprotein(a)Atherosclerosis. Supplements
researchProduct